ZEALAND PHARMA A S (ZEAL)
Institutional ownership reported to the SEC as of Q4 2022, across 17 quarters.
1
Reporting holders
$1.8K
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| TimeScale Financial, Inc. | $1.8K | 100 | 0.00% | 2q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q4 2022 | 1 | $1.8K | 100 | 0 | 0 | 0 | 0.0% |
| Q3 2022 | 1 | $2.0K | 100 | 1 | 0 | 0 | 0.0% |
| Q2 2022 | 11 | $10.4M | 802,784 | 2 | 2 | 2 | 0.0% |
| Q1 2022 | 10 | $12.5M | 805,146 | 0 | 2 | 6 | 0.0% |
| Q4 2021 | 12 | $16.8M | 789,115 | 1 | 3 | 3 | 0.0% |
| Q3 2021 | 14 | $22.0M | 774,860 | 1 | 5 | 3 | 0.0% |
| Q2 2021 | 16 | $39.5M | 1,336,506 | 3 | 2 | 6 | 0.0% |
| Q1 2021 | 16 | $47.9M | 1,498,259 | 5 | 5 | 3 | 0.0% |
| Q4 2020 | 14 | $61.4M | 1,707,906 | 0 | 4 | 4 | 0.0% |
| Q3 2020 | 14 | $63.4M | 1,667,519 | 0 | 3 | 4 | 0.0% |
| Q2 2020 | 16 | $60.1M | 1,716,160 | 1 | 3 | 8 | 0.0% |
| Q1 2020 | 19 | $81.3M | 2,356,045 | 5 | 3 | 4 | 0.0% |
| Q4 2019 | 16 | $88.8M | 2,674,793 | 5 | 4 | 1 | 0.0% |
| Q3 2019 | 13 | $71.7M | 2,826,076 | 2 | 3 | 4 | 0.0% |
| Q2 2019 | 13 | $62.9M | 2,917,956 | 3 | 4 | 3 | 0.0% |
| Q1 2019 | 11 | $47.6M | 2,794,844 | 1 | 1 | 4 | 0.0% |
| Q4 2018 | 13 | $33.0M | 2,841,750 | 0 | 0 | 1 | 0.0% |